A case report: Guillain-Barré syndrome probably associated with TNF inhibitor in Blau syndrome
TNFi therapy is increasing every year, so more attention should be paid to the safety of TNF inhibitor therapy, especially nervous system demyelination. The assessment about nervous system should be recommended in regular follow-up among patients receiving TNFi therapy.
Authors
- Liping Wang (ORCID: https://orcid.org/0000-0002-3458-4513)
- Yanliang Jin
- Xiqiong Han
- Shengfang Bao
- Hua Huang
- Jing Ma
- Zhen Yang
- Yingying Jin
- Fei Ding
- Ruen Yao
- Chenxi Liu
- Xuemei Xu
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Children's Medical Center (CN)
Publication Details
- Journal
- BMC Pediatrics
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1186/s12887-025-05987-w
- Citations
- 1
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 32.84